The ESMO conference stands as a pivotal gathering in the realm of oncology, offering an indispensable platform for the exchange of cutting-edge insights and advancements in cancer research and treatment. Held on an annual basis, these conferences present an inclusive panorama of the latest developments in oncology across diverse subfields.
The DelveInsight team is poised for an exceptional networking experience, connecting with experts and professionals from the global industrial landscape. Our team members will participate in enlightening seminars, engaging oncology workshops, and insightful educational sessions tailored to the specific interests of clinical oncologists and researchers.
DelveInsight will actively engage with the plethora of scientific abstracts featured at the ESMO Congress, delving into the latest breakthroughs and discoveries in cancer clinical trials. This will encompass groundbreaking therapeutic research that is set to transform cancer patient care, revolutionizing the way we approach this critical aspect of healthcare.
Schedule A One-To-One Meeting with Our Experts At ESMO 2023 from October 20-26, 2023.
Join us simply by filling up the form upright.
DelveInsight’s Oncology Conference Coverage Services provided a detailed analysis of conference coverage outcomes of various conferences, including ASCO, ESMO, ASH, AACR, ASTRO, SOHO, SITC, European CAR T-cell Meeting, IASLC 2023, leading to effective competitive intelligence assessment and anticipation of market trends to develop future road maps.
DelveInsight's Oncology Portfolio Management services are unrivaled in understanding skills in the cancer domain. Furthermore, we prioritize strategic goals, analyze developments in the oncology segment, understand the current needs of the oncology market, and seek to provide value for client services.
DelveInsight intends to provide useful reports that are relevant to the rare cancer market. Our analysts monitor competing products’ developmental, regulatory, and commercial milestones. It comprises features such as conference evaluation and company and R&D development evaluation to carry out the desired development of an oncological product for commercial purposes dealing with the client’s area of interest.
Our multidimensional, purposeful, and credible consultancy services will aid in the acceleration of oncology product services, including aspects such as congress intelligence, conference coverage, CI asset/indication tracking, brand presence and penetration assessment, drug therapy uptake, and diagnostic landscape assessment to overcome several oncology market challenges.
We stand out from the crowd by hiring a specialized primary Competitive Intelligence research team. It constitutes analysts, senior analysts, and managers. Our CI force provides the finest opportunity and most accurate intelligence to be obtained and shared with our allies. Furthermore, extraordinary data collecting with the primary purpose of acquiring best-in-class intelligence and offering analysis in relation to our partners’ consulting goals.
Our research and development analyst understands the oncology domain to make value-based judgments and assist clients in achieving superior oncological R&D outcomes. The path of each oncological medicine through pre-clinical and clinical development is completed by evaluating the same factors as other candidates currently in the field. Similar is done for the oncology drugs as well. DelveInsight’s insightful oncological reports clarify uncertainties and challenge blind spots to provide the organization with timely intelligence.
DelveInsight's Oncological Pipeline Assessment promises a comprehensive picture of cancer therapies, clinical trials, and highlights of the cancer therapeutics landscape in a report format. Our Pipeline Assessment report type, which includes oncology-ready reports already available in our Report Store, gives insights across treatments, MoAs, Drugs, APIs, and Launch Insights of therapies in late-stage development to provide awareness of their launch timelines and strategies.
We welcome you to discuss your business-related concerns, and we can together find the best possible solution to help you proceed further in the oncological market.
The ESMO 2023 conference and exhibition will take place at IFEMA MADRID, Avda. Del Partenón, 5, 28042 Madrid, Spain, from 20-26 October 2023.